Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

October 1, 2027

Conditions
Kidney Transplant RecipientsOld Age
Interventions
DRUG

Conversion to extended-release tacrolimus

Conversion from immediate-release tacrolimus (Prograf) to extended-release tacrolimus (Envarsus XR) as a part of the maintenance immunosuppressive treatment

DRUG

Maintenance of immediate-release tacrolimus

Continuing immediate-release tacrolimus (Prograf) as a part of the maintenance immunosuppressive treatment

Trial Locations (1)

02114

MGH Kidney Transplant Clinic, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Massachusetts General Hospital

OTHER